International Business Machines Corporation (IBM)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 27,500.00 |
|---|---|
| 52-week range | 20,830.00 – 33,300.00 |
| Return, 1 month / 3 months | +11.2% / +28.4% |
| Return, 1 year / 3 years | −8.8% / +11.3% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 50.6% |
| Worst drawdown (1 year) | -34.9% |
| Average daily value traded | 1,427.75M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
International Business Machines Corporation, commonly called IBM, is a technology company based in the United States. It supplies computer hardware, software and information technology services to businesses, government agencies and other large organisations around the world. Its offerings include mainframe computers, servers, enterprise software, cloud computing services and consulting work that helps clients design and run their systems. IBM also develops artificial intelligence tools used in business settings.
On this site International Business Machines Corporation appears as a stock on the Buenos Aires Exchange (Argentina), code IBM, with prices in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
International Business Machines Corporation (IBM) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 27,500.00 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 78 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.8% and over the last three months it rose 28.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.3% | ||
| From 52-week high | -17.0% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 28.4% | ||
| 6-month return | 13.1% | ||
| 12-month return, skipping the last month | -18.0% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.9% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 1,427.75M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +9.3% |
|---|---|
| 1 month | +11.2% |
| 3 months | +28.4% |
| 6 months | +13.1% |
| 1 year | −8.8% |
| 3 years | +11.3% |
| 5 years | +932.9% |
Signals
| 50-day / 200-day average | 24,894.20 / 25,387.91 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 812.80 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2026 | USD 170.9722 |
| 8 May 2026 | USD 170.9722 |
| 10 Feb 2026 | USD 169.9600 |
| 10 Nov 2025 | USD 169.9600 |
| 8 Aug 2025 | USD 169.9600 |
| 9 May 2025 | USD 169.9600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.